Skip to content
Screener

Opko Health OPK Total costs & expenses

Total costs & expenses at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$2.58B+11.2%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$46.93M+15.7%
Regenxbio logo
RegenxbioRGNX
$78.76M-6.9%
Exelixis logo
ExelixisEXEL
$380.28M+7.2%
PTH
Pelthos TherapeuticsPTHS
$23.99M+1,208%
ALN
Alnylam PharmaceuticalsALNY
$1.06B+34.1%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$1.04B+0.5%
P/S1.8×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
Line itemFor the three months ended June 30, 2026For the three months ended June 30, 2025For the six months ended June 30, 2026For the six months ended June 30, 2025
Research and development33,16630,34262,36561,183
Amortization of intangible assets18,96919,44437,93539,304
Gain on sale of assets(18,070)(18,070)
Total costs and expenses170,552216,788345,764433,907
Operating loss(6,972)(59,981)(57,987)(127,148)
Other income (expense), net:
Interest income3,2213,2876,2287,968
Interest expense(11,380)(70,327)(22,319)(85,794)

Item 1. Financial Statements

FAQ

What is Opko Health's total costs & expenses?
Opko Health (OPK) reported total costs & expenses of $170.55M in Q2 2026.
How has Opko Health's total costs & expenses changed year-over-year?
Opko Health's total costs & expenses decreased by 21.3% year-over-year, from $216.79M to $170.55M.
What is the long-term trend for Opko Health's total costs & expenses?
Over 3 years (2022 to 2025), Opko Health's total costs & expenses has grown at a -16.2% compound annual growth rate (CAGR), from $1.23B to $724.29M.
What does total costs & expenses mean?
This metric aggregates all operating and non-operating costs incurred by the company to generate revenue, including cost of goods sold, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the company's total expenditure burden during a reporting period. Monitoring this helps evaluate the company's cost structure and operational efficiency relative to its revenue generation.

Ask your AI about Opko Health's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude